Chagas disease diagnostic criteria: Difference between revisions

Jump to navigation Jump to search
(Created page with " Careful consideration of the patient’s history to identify possible risks for infection may be helpful. Acute infections can be diagnosed by the identification of trypomast...")
 
No edit summary
 
Line 1: Line 1:
 
==Overview==
Careful consideration of the patient’s history to identify possible risks for infection may be helpful. Acute infections can be diagnosed by the identification of trypomastigotes in blood by microscopy. During the chronic phase, circulating parasite levels decrease rapidly within a few months and are undetectable.  
Careful consideration of the patient’s history to identify possible risks for infection may be helpful. Acute infections can be diagnosed by the identification of trypomastigotes in blood by microscopy. During the chronic phase, circulating parasite levels decrease rapidly within a few months and are undetectable.  
Chronic Chagas disease is made by serologic tests for antibodies to the parasite. A single test is not sufficiently sensitive and specific to make the diagnosis. For this reason, the standard approach is to apply two or more tests that use different techniques and that detect antibodies to different antigens. Commonly used techniques include enzyme-linked immunosorbent assay (ELISA) and immunofluorescent antibody test (IFA).
Chronic Chagas disease is made by serologic tests for antibodies to the parasite. A single test is not sufficiently sensitive and specific to make the diagnosis. For this reason, the standard approach is to apply two or more tests that use different techniques and that detect antibodies to different antigens. Commonly used techniques include enzyme-linked immunosorbent assay (ELISA) and immunofluorescent antibody test (IFA).
<br />
==Diagnostic criteria ==
Careful consideration of the patient’s history to identify possible risks for infection may be helpful. Acute infections can be diagnosed by the identification of trypomastigotes in blood by microscopy. During the chronic phase, circulating parasite levels decrease rapidly within a few months and are undetectable. Chronic Chagas disease is made by serologic tests for antibodies to the parasite. A single test is not sufficiently sensitive and specific to make the diagnosis. For this reason, the standard approach is to apply two or more tests that use different techniques and that detect antibodies to different antigens. Commonly used techniques include enzyme-linked immunosorbent assay (ELISA) and immunofluorescent antibody test (IFA).

Latest revision as of 21:25, 12 February 2020

Overview

Careful consideration of the patient’s history to identify possible risks for infection may be helpful. Acute infections can be diagnosed by the identification of trypomastigotes in blood by microscopy. During the chronic phase, circulating parasite levels decrease rapidly within a few months and are undetectable. Chronic Chagas disease is made by serologic tests for antibodies to the parasite. A single test is not sufficiently sensitive and specific to make the diagnosis. For this reason, the standard approach is to apply two or more tests that use different techniques and that detect antibodies to different antigens. Commonly used techniques include enzyme-linked immunosorbent assay (ELISA) and immunofluorescent antibody test (IFA).

Diagnostic criteria

Careful consideration of the patient’s history to identify possible risks for infection may be helpful. Acute infections can be diagnosed by the identification of trypomastigotes in blood by microscopy. During the chronic phase, circulating parasite levels decrease rapidly within a few months and are undetectable. Chronic Chagas disease is made by serologic tests for antibodies to the parasite. A single test is not sufficiently sensitive and specific to make the diagnosis. For this reason, the standard approach is to apply two or more tests that use different techniques and that detect antibodies to different antigens. Commonly used techniques include enzyme-linked immunosorbent assay (ELISA) and immunofluorescent antibody test (IFA).